Viewing Study NCT04671160

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:08 AM
Ignite Modification Date: 2026-02-09 @ 1:55 PM
Study NCT ID: NCT04671160
Status: UNKNOWN
Last Update Posted: 2020-12-17
First Post: 2020-12-08
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Impact of Continuous Veno-venous Hemodiafiltration on Efficacy of Administration of Prophylactic Doses of Enoxaparin or Fondaparinux in Critically Ill Patients.
Sponsor: Medical University of Gdansk
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Assessment of Activity of Anti-Xa Factor in Patients Treated With … View
Keywords:

Keywords

Keyword Brief Keyword Text View
None continuous veno-venous hemodiafiltration View
None enoxaparin View
None low molecular weight heparin View
None LMWH View
None CVVHDF View
None anticoagulant prophylaxis View
None critically ill View
None fondaparinux View
None anti-Xa activity View